Trial comparisons

curl "https://conductscience.org/api/comparisons/v1?page=130"

Response

The first 2 of this page's 20 results. GET /api/comparisons/v1?page=130

{
  "data": {
    "total": 85013,
    "results": [
      {
        "id": "NCT00072462-sae",
        "title": "Anastrozole vs Tamoxifen: serious adverse events",
        "summary": "333 of 1449 against 371 of 1489; risk difference -1.9 points, 95% interval -5.0 to 1.2; NCT00072462, Adjuvant Tamoxifen Compared With Anastrozole in Treating Postmenopausal Women With Ductal Carcinoma In Situ",
        "record": "/library/comparisons/NCT00072462-sae",
        "nct_id": "NCT00072462",
        "kind": "serious-adverse-events",
        "participants": 2938,
        "risk_difference": {
          "value": -0.01934684581339763,
          "lower": -0.05014735273083506,
          "upper": 0.011537631464459911
        },
        "group_1": "333 of 1,449",
        "group_2": "371 of 1,489",
        "difference": "-1.9 points",
        "interval": "-5.0 to 1.2",
        "trial_title": "Adjuvant Tamoxifen Compared With Anastrozole in Treating Postmenopausal Women With Ductal Carcinoma In Situ"
      },
      {
        "id": "NCT01306331-sae",
        "title": "Conceptrol vs Amphora: serious adverse events",
        "summary": "19 of 1477 against 11 of 1458; risk difference 0.5 points, 95% interval -0.2 to 1.3; NCT01306331, Study of Contraceptive Efficacy & Safety of Phexxi™ (Previously Known as Amphora) Gel Compared to Conceptrol Vaginal Gel",
        "record": "/library/comparisons/NCT01306331-sae",
        "nct_id": "NCT01306331",
        "kind": "serious-adverse-events",
        "participants": 2935,
        "risk_difference": {
          "value": 0.005319331719191295,
          "lower": -0.002181768420619348,
          "upper": 0.013196788038202864
        },
        "group_1": "19 of 1,477",
        "group_2": "11 of 1,458",
        "difference": "0.5 points",
        "interval": "-0.2 to 1.3",
        "trial_title": "Study of Contraceptive Efficacy & Safety of Phexxi™ (Previously Known as Amphora) Gel Compared to Conceptrol Vaginal Gel"
      }
    ],
    "no_events": 33758,
    "columns": [
      {
        "key": "title",
        "label": "Comparison"
      },
      {
        "key": "group_1",
        "label": "With the outcome",
        "under": "group_2"
      },
      {
        "key": "difference",
        "label": "Risk difference, 95% interval",
        "under": "interval"
      },
      {
        "key": "participants",
        "label": "Participants"
      },
      {
        "key": "nct_id",
        "label": "Trial",
        "under": "trial_title"
      }
    ],
    "order": "Most participants first",
    "kinds": {
      "all": 85013,
      "outcome": 33568,
      "serious-adverse-events": 31897,
      "deaths": 19548
    }
  },
  "release": "trial-comparisons-2026-03-23-0.1.0",
  "terms": [
    {
      "source": "ClinicalTrials.gov's posted results, through CTTI's AACT",
      "license": "ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299",
      "notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.",
      "short": "Freely available. Acknowledgement requested"
    },
    {
      "source": "ClinicalTrials.gov",
      "license": "none stated",
      "notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.",
      "short": "No license stated"
    }
  ],
  "next": "/api/comparisons/v1?page=131",
  "request_id": "ZKAfLBVu_qLMvdr1"
}